Management of Phlebitis
Immediate Action Required
Remove the peripheral venous catheter immediately if any signs of phlebitis develop (warmth, tenderness, erythema, palpable venous cord, induration, or swelling)—catheter removal is mandatory, not optional. 1, 2
This is the single most critical intervention, and failing to remove the catheter promptly is the most common management error. 2
Initial Assessment and Workup
- Inspect the insertion site for pain, induration, erythema, exudate, or palpable venous cord. 2
- Submit any exudate from the insertion site for Gram staining and culture (including fungal and acid-fast organisms in immunocompromised patients). 2
- Obtain compression ultrasound if there is concern for superficial vein thrombosis extending ≥5 cm or within 3 cm of the saphenofemoral junction. 3, 2
- Grade severity using the Baxter scale (grades 0-5) based on clinical symptoms—grades 4-5 warrant consideration for early surgical intervention. 4
Symptomatic Treatment for Simple Phlebitis
- Apply warm compresses to the affected area. 2
- Elevate the affected limb to reduce swelling and promote venous drainage. 2, 5
- Use NSAIDs for pain control unless contraindicated (avoid if platelets <20,000-50,000/mcL or severe platelet dysfunction). 3, 2
When to Initiate Anticoagulation
Anticoagulation is NOT routinely indicated for simple catheter-related phlebitis. 2
However, anticoagulation is required in specific scenarios:
- If superficial vein thrombosis extends ≥5 cm in length: Treat with fondaparinux 2.5 mg subcutaneously daily for 45 days (first-line) or rivaroxaban 10 mg orally daily for 45 days (alternative if parenteral therapy is not feasible). 3, 2
- If thrombosis is within 3 cm of the saphenofemoral junction: Escalate to therapeutic-dose anticoagulation for at least 3 months, treating as DVT-equivalent. 3, 2
- If superficial vein thrombosis is <5 cm or below the knee: Consider repeat ultrasound in 7-10 days to assess for progression; initiate anticoagulation if progression is documented. 3
Management of Septic Phlebitis
- Start empiric antibiotics immediately, with vancomycin recommended for empiric coverage given high rates of methicillin resistance. 2
- Target gram-positive organisms (Staphylococcus aureus in 41% of cases, Group A streptococcus in 20%). 5
- If clinical deterioration occurs or septicemia persists after 24 hours despite conservative therapy: Perform operative excision of the involved vein. 5
- Monitor for complications including septic pulmonary emboli, which can develop rapidly in severe cases. 6
Prevention Strategies to Avoid Future Phlebitis
- Replace peripheral venous catheters every 72-96 hours in adults to prevent phlebitis. 1, 2
- Use upper extremity sites preferentially over lower extremity sites. 1, 2
- Avoid the cubital fossa region as the first site of choice for cannulation, as this region is vulnerable to severe phlebitis requiring surgical intervention. 4
- Consider midline catheters or PICCs when IV therapy will likely exceed 6 days. 1, 2
- Use the smallest gauge catheter possible and prefer polyurethane or silicone catheters over Teflon. 2
- Maintain proper asepsis with topical use of >0.5% chlorhexidine preparation with 70% alcohol or 2% aqueous chlorhexidine, proper hand hygiene, and clean gloves for handling connections. 7
- Be aware that certain antibiotics (dicloxacillin, erythromycin, benzylpenicillin, cefuroxime, cloxacillin) have a greater tendency to cause phlebitis compared to others (ampicillin, imipenem/cilastatin, clindamycin, netilmicin, vancomycin). 8
Special Considerations for Sickle Cell Disease Patients
- Inspect IV cannula sites regularly for phlebitis and remove immediately if there are signs of redness or swelling, as these patients are more susceptible to infection. 9
- Maintain vigilance for infection as it may precipitate sickle complications such as painful crisis or acute chest syndrome. 9
Critical Pitfalls to Avoid
- Failing to remove the catheter promptly is the most common error—catheter removal is mandatory, not optional. 1, 2
- Treating simple catheter-related phlebitis with anticoagulation when it is not indicated (reserve anticoagulation for documented superficial vein thrombosis ≥5 cm or near the saphenofemoral junction). 2
- Inadequate treatment duration when anticoagulation is indicated—the evidence-based duration is 45 days for superficial vein thrombosis ≥5 cm, not shorter courses. 3, 2
- Using prophylactic-dose anticoagulation instead of therapeutic-dose when thrombosis is within 3 cm of the saphenofemoral junction. 2